Prime Medicine, Inc. Common Stock (PRME) — Defensive Interval Ratio
Prime Medicine, Inc. Common Stock (PRME) has a Defensive Interval Ratio of 548 days as of June 2026. Defensive assets of $47.62 Million (cash $-, short-term investments $47.62 Million, receivables $-) cover 548 days of daily cash needs of $86.83K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Prime Medicine, Inc. Common Stock Defensive Interval Ratio (2020–2025)
This chart shows how Prime Medicine, Inc. Common Stock's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 548 days, meaning defensive assets of $47.62 Million can fund 548 days of operations without new revenue. For the complete balance sheet picture, see PRME total asset value.
Annual Defensive Interval Ratio for Prime Medicine, Inc. Common Stock (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Prime Medicine, Inc. Common Stock from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See PRME current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1117 days | $114.65 Million | $102.60K/day | $- | $114.65 Million | ▲ +1041 days |
| 2024 | 77 days | $7.97 Million | $104.00K/day | $- | $7.97 Million | ▼ -442 days |
| 2023 | 518 days | $80.09 Million | $154.58K/day | $- | $80.09 Million | ▼ -934 days |
| 2022 | 1452 days | $106.30 Million | $73.19K/day | $- | $106.30 Million | ▲ +922 days |
| 2021 | 530 days | $84.20 Million | $158.86K/day | $- | $84.20 Million | ▲ +223 days |
| 2020 | 307 days | $16.35 Million | $53.27K/day | $- | $16.35 Million | — |